Details for New Drug Application (NDA): 012775
✉ Email this page to a colleague
NDA 012775 describes ENDURONYL FORTE, which is a drug marketed by Abbott and is included in one NDA. Additional details are available on the ENDURONYL FORTE profile page.
The generic ingredient in ENDURONYL FORTE is deserpidine; methyclothiazide. There are four drug master file entries for this compound. Additional details are available on the deserpidine; methyclothiazide profile page.
The generic ingredient in ENDURONYL FORTE is deserpidine; methyclothiazide. There are four drug master file entries for this compound. Additional details are available on the deserpidine; methyclothiazide profile page.
Summary for 012775
| Tradename: | ENDURONYL FORTE |
| Applicant: | Abbott |
| Ingredient: | deserpidine; methyclothiazide |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 0.25MG;5MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 0.5MG;5MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
